OFIX · Orthofix Medical Inc.
$10.34
+0.16 (+1.57%)
At close · Aug 14
Market Cap
$421.18M
Shares
40.73M
Orthofix Medical Inc. Earnings Call Transcripts
Every quarterly earnings call for Orthofix Medical Inc. (OFIX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲1.4%
$114.00M
−$10.72M
'22 Q3
22-11-03
▼2.3%
$122.23M
−$7.06M
'22 Q4
23-03-06
▲64.6%
$175.20M
−$60.94M
'23 Q1
23-05-09
▲58.4%
$187.02M
−$39.43M
'23 Q2
23-08-08
▲61.4%
$184.01M
−$28.86M
'23 Q3
23-11-08
▲64%
$200.41M
−$22.17M
'23 Q4
24-03-05
▲7.7%
$188.61M
−$36.02M
'24 Q1
24-05-07
▲6.2%
$198.62M
−$33.44M
'24 Q2
24-08-06
▲6.8%
$196.61M
−$27.39M
'24 Q3
24-11-07
▲7.6%
$215.66M
−$29.15M
'24 Q4
25-02-25
▲2.7%
$193.65M
−$53.09M
'25 Q1
25-05-06
▲2.3%
$203.12M
−$14.08M
'25 Q2
25-08-05
▲4.6%
$205.63M
−$22.80M
'25 Q3
25-11-04
▲2%
$219.91M
−$2.22M
'25 Q4
26-02-24
▲1.6%
$196.71M
−$20.91M
'26 Q1
26-05-05
LATEST
▲3.8%
$210.93M
−$15.80M
'26 Q2
26-08-05
Conference
Investor event
2026-08-12
Canaccord Genuity's 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-05
Orthofix Medical Q2 2026 Earnings Call
Positive tone
Global Limb Reconstruction Expansion
Disciplined Transformation and Commercial Execution
Biologics Recovery
Revenue
$210.93M
▲ 3.8% YoY Diluted EPS
$-0.39
Gross margin
71.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Orthofix Medical Inc. Q1 FY2026 Earnings Call
Positive tone
Biologics recovery
Macro and geopolitical headwinds
Innovation pipeline and VIRATA launch
Revenue
$196.71M
▲ 1.6% YoY Diluted EPS
$-0.52
Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-03
TD Cowen Health Care Conference Fireside Chat
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-02
CG 2026 Musculoskeletal Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-24
Orthofix Medical Inc. Q4 FY2025 Earnings Call
Confident tone
Tariffs and Legal Settlements
Limb Reconstruction Growth
Bone Growth Therapies
Revenue
$219.91M*
▲ 2% YoY Gross margin
71.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2025-11-12
Stifel 2025 Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-04
Orthofix Medical Inc. Q3 FY2025 Earnings Call
Confident tone
U.S. Spine Fixation growth and distributor transitions
Orthopedics segment and TrueLok Elevate
M6 artificial disc discontinuation (pro forma basis)
Revenue
$205.63M
▲ 4.6% YoY Diluted EPS
$-0.57
Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Orthofix Medical Inc. Q2 FY2025 Earnings Call
Confident tone
Bone Growth Therapies (BGT)
Orthopedics and Limb Reconstruction
7D FLASH Navigation and VIRATA Launch
Revenue
$203.12M
▲ 2.3% YoY Diluted EPS
$-0.36
Gross margin
68.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Orthofix Medical Inc. Q1 FY2025 Earnings Call
Positive tone
Bone Growth Therapies / AccelStim 2.0
Capital allocation and three-year plan
Global Orthopedics / TrueLok Elevate
Revenue
$193.65M
▲ 2.7% YoY Diluted EPS
$-1.35
Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Orthofix Medical Inc. Q4 FY2024 Earnings Call
Confident tone
Growth and Innovation Across Product Lines
Orthopedics / Limb Reconstruction
Strategic / Vital Few Initiatives
Revenue
$215.66M*
▲ 7.6% YoY Gross margin
69.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Orthofix Medical Inc. Q3 FY2024 Earnings Call
Confident tone
Innovation and Product Launches
Bone Growth Therapy (BGT)
Profitability and Cash Flow
Revenue
$196.61M
▲ 6.8% YoY Diluted EPS
$-0.71
Gross margin
68.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Orthofix Medical Inc. Q2 FY2024 Earnings Call
Confident tone
7D FLASH Navigation System
Revenue Growth and Portfolio Performance
SeaSpine Merger Integration
Revenue
$198.62M
▲ 6.2% YoY Diluted EPS
$-0.88
Gross margin
67.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Orthofix Medical Inc. Q1 FY2024 Earnings Call
Confident tone
Revenue growth and segment performance
Profitability and adjusted EBITDA margin
Working capital and cash flow
Revenue
$188.61M
▲ 7.7% YoY Diluted EPS
$-0.95
Gross margin
67.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Orthofix Medical Inc. Q4 FY2023 Earnings Call
Positive tone
Spine franchise and distribution
Mergers, transition and SeaSpine combination
Profitable growth and margins
Revenue
$200.41M*
▲ 64% YoY Gross margin
68.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Orthofix Medical Inc. Q3 FY2023 Earnings Call
Revenue
$184.01M
▲ 61.4% YoY Diluted EPS
$-0.77
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Orthofix Medical Inc. Q2 FY2023 Earnings Call
Revenue
$187.02M
▲ 58.4% YoY Diluted EPS
$-1.07
▼ 991.7% YoY Gross margin
63.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Orthofix Medical Inc. Q1 FY2023 Earnings Call
Revenue
$175.20M
▲ 64.6% YoY Diluted EPS
$-1.71
Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Orthofix Medical Inc. Q4 FY2022 Earnings Call
Revenue
$122.23M*
▼ 2.3% YoY Gross margin
73.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Orthofix Medical Inc. Q3 FY2022 Earnings Call
Revenue
$114.00M
▲ 1.4% YoY Diluted EPS
$-0.53
▼ 581.8% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-05
Orthofix Medical Inc. Q2 FY2022 Earnings Call
Revenue
$118.07M
▼ 2.7% YoY Diluted EPS
$0.12
▲ 0% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-06
Orthofix Medical Inc. Q1 FY2022 Earnings Call
Revenue
$106.42M
▲ 0.8% YoY Diluted EPS
$-0.22
Gross margin
73.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-25
Orthofix Medical Inc. Q4 FY2021 Earnings Call
Revenue
$125.06M*
▲ 6.3% YoY Gross margin
73.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-05
Orthofix Medical Inc. Q3 FY2021 Earnings Call
Revenue
$112.43M
▲ 1.3% YoY Diluted EPS
$0.11
▼ 54.2% YoY Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Orthofix Medical Inc. Q2 FY2021 Earnings Call
Revenue
$121.39M
▲ 66% YoY Diluted EPS
$0.12
Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Orthofix Medical Inc. Q1 FY2021 Earnings Call
Revenue
$105.59M
▲ 0.7% YoY Diluted EPS
$-0.30
▼ 122.7% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-26
Orthofix Medical Inc. Q4 FY2020 Earnings Call
Revenue
$117.62M*
▼ 3.2% YoY Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Orthofix Medical Inc. Q3 FY2020 Earnings Call
Revenue
$110.98M
▼ 2.2% YoY Diluted EPS
$0.24
Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Orthofix Medical Inc. Q2 FY2020 Earnings Call
Revenue
$73.14M
▼ 36.9% YoY Diluted EPS
$-0.96
Gross margin
68.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-08
Orthofix Medical Inc. Q1 FY2020 Earnings Call
Revenue
$104.82M
▼ 3.9% YoY Diluted EPS
$1.32
▲ 2540% YoY Gross margin
77.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Orthofix Medical Inc. Q4 FY2019 Earnings Call
Revenue
$121.49M*
▲ 0.3% YoY Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 earnings calls
Key facts
CIK
884624
CUSIP
68752M108
13F (30d)
132 filings
130 filers
Visit website
Investor relations